United Therapeutics(UTHR) - 2024 Q2 - Quarterly Report

Part I. Financial Information | --- | --- | --- | --- | --- | |-------------------------------------|-------|----------------------------|-----------------------------|----------------------| | Due within one year | $| Amortized Cost \n 1,632.2 | As of June 30, 2024 \n \n$ | Fair Value \n1,622.1 | | Due in one to three years | | 1,337.2 | | 1,330.4 | | Total | $| 2,969.4 |$ | 2,952.5 | As of June 30, 2024 and December 31, 2023, we maintained non-controlling equity investments in privately-held companies ...